#METABOLOMICS WORKBENCH XiaoyangSu_20250619_134448 DATATRACK_ID:6065 STUDY_ID:ST004015 ANALYSIS_ID:AN006620 PROJECT_ID:PR002513 VERSION 1 CREATED_ON June 19, 2025, 4:51 pm #PROJECT PR:PROJECT_TITLE SLC45A4 encodes a peroxisomal putrescine transporter that promotes GABA de novo PR:PROJECT_TITLE synthesis PR:PROJECT_TYPE Cellular polar metabolomics PR:PROJECT_SUMMARY Solute carriers (SLC) are membrane proteins that facilitate the transportation PR:PROJECT_SUMMARY of ions and metabolites across either the plasma membrane or the membrane of PR:PROJECT_SUMMARY intracellular organelles. With more than 450 human genes annotated as SLCs, many PR:PROJECT_SUMMARY of them are still orphan transporters without known biochemical functions. We PR:PROJECT_SUMMARY developed a metabolomic-transcriptomic association analysis, and we found that PR:PROJECT_SUMMARY the expression of SLC45A4 has a strong positive correlation with the cellular PR:PROJECT_SUMMARY level of γ-aminobutyric acid (GABA). Using mass spectrometry and the stable PR:PROJECT_SUMMARY isotope tracing approach, we demonstrated that SLC45A4 promotes GABA de novo PR:PROJECT_SUMMARY synthesis through the Arginine/Ornithine/Putrescine (AOP) pathway. SLC45A4 PR:PROJECT_SUMMARY functions as a putrescine transporter localized to the peroxisome membrane to PR:PROJECT_SUMMARY facilitate GABA production. Taken together, our results revealed a new PR:PROJECT_SUMMARY biochemical mechanism where SLC45A4 controls GABA production. PR:INSTITUTE Rutgers University PR:DEPARTMENT Department of Medicine PR:LAST_NAME Su PR:FIRST_NAME Xiaoyang PR:ADDRESS 7118 Clinical Academic Building PR:EMAIL xs137@rwjms.rutgers.edu PR:PHONE 7322355447 PR:FUNDING_SOURCE R01 GM149664 #STUDY ST:STUDY_TITLE SLC45A4 encodes a peroxisomal putrescine transporter that promotes GABA de novo ST:STUDY_TITLE synthesis ST:STUDY_SUMMARY We found that the expression of SLC45A4 has a strong positive correlation with ST:STUDY_SUMMARY the cellular level of γ-aminobutyric acid (GABA). Using mass spectrometry and ST:STUDY_SUMMARY the stable isotope tracing approach, we demonstrated that SLC45A4 promotes GABA ST:STUDY_SUMMARY de novo synthesis through the Arginine/Ornithine/Putrescine (AOP) pathway. ST:STUDY_SUMMARY SLC45A4 functions as a putrescine transporter localized to the peroxisome ST:STUDY_SUMMARY membrane to facilitate GABA production. Taken together, our results revealed a ST:STUDY_SUMMARY new biochemical mechanism where SLC45A4 controls GABA production. ST:INSTITUTE Rutgers University ST:DEPARTMENT Department of Medicine ST:LAST_NAME Su ST:FIRST_NAME Xiaoyang ST:ADDRESS 7118 Clinical Academic Building ST:EMAIL xs137@rwjms.rutgers.edu ST:PHONE 17322355447 #SUBJECT SU:SUBJECT_TYPE Cultured cells SU:SUBJECT_SPECIES Homo sapiens SU:TAXONOMY_ID 9606 SU:CELL_STRAIN_DETAILS A549, H1299 #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data SUBJECT_SAMPLE_FACTORS - lysate_A549_KD45A4_1 Sample source:Lysate | Cell line:A549 | Knockdown:SLC45A4 RAW_FILE_NAME(Raw file name)=lysate_A549_KD45A4_1.mzXML SUBJECT_SAMPLE_FACTORS - lysate_A549_KD45A4_2 Sample source:Lysate | Cell line:A549 | Knockdown:SLC45A4 RAW_FILE_NAME(Raw file name)=lysate_A549_KD45A4_2.mzXML SUBJECT_SAMPLE_FACTORS - lysate_A549_KD45A4_3 Sample source:Lysate | Cell line:A549 | Knockdown:SLC45A4 RAW_FILE_NAME(Raw file name)=lysate_A549_KD45A4_3.mzXML SUBJECT_SAMPLE_FACTORS - lysate_A549_siCtr_1 Sample source:Lysate | Cell line:A549 | Knockdown:Ctrl RAW_FILE_NAME(Raw file name)=lysate_A549_siCtr_1.mzXML SUBJECT_SAMPLE_FACTORS - lysate_A549_siCtr_2 Sample source:Lysate | Cell line:A549 | Knockdown:Ctrl RAW_FILE_NAME(Raw file name)=lysate_A549_siCtr_2.mzXML SUBJECT_SAMPLE_FACTORS - lysate_A549_siCtr_3 Sample source:Lysate | Cell line:A549 | Knockdown:Ctrl RAW_FILE_NAME(Raw file name)=lysate_A549_siCtr_3.mzXML SUBJECT_SAMPLE_FACTORS - lysate_H1299_KD45A4_1 Sample source:Lysate | Cell line:H1299 | Knockdown:SLC45A4 RAW_FILE_NAME(Raw file name)=lysate_H1299_KD45A4_1.mzXML SUBJECT_SAMPLE_FACTORS - lysate_H1299_KD45A4_2 Sample source:Lysate | Cell line:H1299 | Knockdown:SLC45A4 RAW_FILE_NAME(Raw file name)=lysate_H1299_KD45A4_2.mzXML SUBJECT_SAMPLE_FACTORS - lysate_H1299_KD45A4_3 Sample source:Lysate | Cell line:H1299 | Knockdown:SLC45A4 RAW_FILE_NAME(Raw file name)=lysate_H1299_KD45A4_3.mzXML SUBJECT_SAMPLE_FACTORS - lysate_H1299_siCtr_1 Sample source:Lysate | Cell line:H1299 | Knockdown:Ctrl RAW_FILE_NAME(Raw file name)=lysate_H1299_siCtr_1.mzXML SUBJECT_SAMPLE_FACTORS - lysate_H1299_siCtr_2 Sample source:Lysate | Cell line:H1299 | Knockdown:Ctrl RAW_FILE_NAME(Raw file name)=lysate_H1299_siCtr_2.mzXML SUBJECT_SAMPLE_FACTORS - lysate_H1299_siCtr_3 Sample source:Lysate | Cell line:H1299 | Knockdown:Ctrl RAW_FILE_NAME(Raw file name)=lysate_H1299_siCtr_3.mzXML #COLLECTION CO:COLLECTION_SUMMARY 0.5×10^6 cells in the culture were washed twice with PBS and extracted with 0.5 CO:COLLECTION_SUMMARY ml ice-cold 40:40:20 (methanol:acetonitrile:water) solution with 0.5% formic CO:COLLECTION_SUMMARY acid. The cells were scraped off the plate followed by incubation on ice for 10 CO:COLLECTION_SUMMARY min, and neutralized by the addition of 25 μl 15% (m/v) NH4HCO3 solution. The CO:COLLECTION_SUMMARY extracts were transferred to a 1.5 ml tube. For conditioned media metabolite CO:COLLECTION_SUMMARY extraction, 5 µl of culture media was mixed with 500 µl of ice-cold 40:40:20 CO:COLLECTION_SUMMARY (methanol:acetonitrile:water) solution with 0.5% formic acid and neutralized by CO:COLLECTION_SUMMARY the addition of 25 μl 15% (m/v) NH4HCO3 solution. The whole cell or media CO:COLLECTION_SUMMARY extracts were then centrifuged at 4°C and 16,000 × g for 10 min and CO:COLLECTION_SUMMARY transferred to a clean tube and stored at -80°C until analysis. CO:SAMPLE_TYPE Cultured cells #TREATMENT TR:TREATMENT_SUMMARY A549 or H1299 cells were seeded in 6-well plates at the density of 2×105 / ml. TR:TREATMENT_SUMMARY When the cells reached about 70% confluence, cells were transfected with siRNA TR:TREATMENT_SUMMARY Transfection Reagent (Santa Cruz Biotechnology, sc-29528) according to TR:TREATMENT_SUMMARY manufacturer’s instructions. siRNAs targeting human SLC45A4 (SCBT, sc-77846) TR:TREATMENT_SUMMARY and non-targeting Scramble controls (SCBT, sc-37007) were obtained from SCBT and TR:TREATMENT_SUMMARY re-suspended at 10 μM in RNAse free water. 4 μl siRNA (20 nM) was first mixed TR:TREATMENT_SUMMARY with 100 μl Opti-MEM (Gibco, 31985070), then mixed with 4 μl siRNA TR:TREATMENT_SUMMARY Transfection Reagent contained in another 100 μl Opti-MEM. The mixture was TR:TREATMENT_SUMMARY incubated at room temperature for 30 min and mixed with 800 μl Opti-MEM. Cells TR:TREATMENT_SUMMARY were washed once with 2 ml Opti-MEM, then covered with 1 ml siRNA mixture and TR:TREATMENT_SUMMARY incubated for 6 hours at 37 °C, 5% CO2. After the incubation, 1 ml of RPMI TR:TREATMENT_SUMMARY 1640 media with 20% FBS and 2× Penicillin-Streptomycin were added. #SAMPLEPREP SP:SAMPLEPREP_SUMMARY The whole cell extracts were then centrifuged at 4°C and 16,000 × g for 10 min SP:SAMPLEPREP_SUMMARY and transferred to a clean tube and stored at -80°C until analysis. #CHROMATOGRAPHY CH:CHROMATOGRAPHY_TYPE HILIC CH:INSTRUMENT_NAME Thermo Vanquish CH:COLUMN_NAME Waters XBridge BEH Amide (150 mm × 2.1 mm, 2.5um) CH:SOLVENT_A 95%:5% H2O:acetonitrile with 20 mM acetic acid, 40 mM ammonium hydroxide, pH 9.4 CH:SOLVENT_B 0%:80% H2O:acetonitrile with 20 mM acetic acid, 40 mM ammonium hydroxide, pH 9.4 CH:FLOW_GRADIENT 0 min, 100% B; 3 min, 100% B; 3.2 min, 90% B; 6.2 min, 90% B; 6.5 min, 80% B; CH:FLOW_GRADIENT 10.5 min, 80% B; 10.7 min, 70% B; 13.5 min, 70% B; 13.7 min, 45% B; 16 min, 45% CH:FLOW_GRADIENT B; 16.5 min, 100% B; and 22 min, 100% B CH:FLOW_RATE 0.3ml/min CH:COLUMN_TEMPERATURE 25 #ANALYSIS AN:ANALYSIS_TYPE MS AN:LABORATORY_NAME Metabolomics Shared Resource of Rutgers Cancer Institute AN:DETECTOR_TYPE Orbitrap AN:DATA_FORMAT mzXML #MS MS:INSTRUMENT_NAME Thermo Q Exactive Plus Orbitrap MS:INSTRUMENT_TYPE Orbitrap MS:MS_TYPE ESI MS:ION_MODE POSITIVE MS:MS_COMMENTS The mass spectrometry analysis was performed on Thermo Q Exactive PLUS MS:MS_COMMENTS instrument with a HESI source, which was set to a spray voltage of −2.7 kV in MS:MS_COMMENTS negative mode and 3.5 kV in positive mode. The sheath, auxiliary, and sweep gas MS:MS_COMMENTS flow rates were 40, 10, and 2 (arbitrary units), respectively. The capillary MS:MS_COMMENTS temperature was set to 300°C, and the aux gas heater was set to 360°C. The MS:MS_COMMENTS S-lens RF level was 45. The m/z scan range was set to 72 to 1000 m/z in either MS:MS_COMMENTS positive or negative ionization mode. The AGC target was set to 3e6, and the MS:MS_COMMENTS maximum IT was 200 ms. Metabolite data were obtained using the El-MAVEN software MS:MS_COMMENTS package (mass accuracy window: 5 ppm). All isotope natural abundance corrections MS:MS_COMMENTS were done using AccuCor (single-isotope labeling) or AccuCor2 (dual-isotope MS:MS_COMMENTS labeling). MS:CAPILLARY_TEMPERATURE 300C MS:ION_SPRAY_VOLTAGE 3.5kV MS:MS_RESULTS_FILE ST004015_AN006620_Results.txt UNITS:Ion counts Has m/z:Yes Has RT:Yes RT units:Minutes #END